Chicken was the crazy guy
Save Dihexa is an angiotensin-IV-derived oligopeptide marketed as a research nootropic, and its honest safety picture starts with an absence: there are no published human clinical trials of Dihexa, and therefore no human safety, toxicology, or pharmacokinetic data of any kind
Weight management physicians, sports medicine clinicians, and compounding pharmacists evaluating metabolic peptide therapy protocols will find a full clinical guide, mechanism overview, stacking strategies, and dosing framework below
Diane Brzezinskis approach to peptide therapy in Naples is grounded in holistic, evidence-based medicine, using FDA-approved peptides tailored to each patients specific health picture
We review your medications, medical conditions and goals before starting any peptide protocol
To get started with compounds you can trust, we invite you to explore our offerings